Trial site
Centro Hospitalar Universitario Sao Joao E.P.E.
- 9running trials
- 8closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease2 trials
- Head and neck cancer2 trials
- Ulcerative colitis2 trials
- Atrial fibrillation1 trial
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Diabetic eye disease1 trial
- Eosinophilic oesophagitis1 trial
- Fabry disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Haemophilia1 trial
- HIV1 trial
- Lung cancer1 trial
- and 3 more
- Phase
- Phase 314 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting8 trials
- Completed8 trials
- Recruiting1 trial
- Lead sponsor
- AbbVie2 trials
- Janssen Research & Development, LLC2 trials
- Novo Nordisk A/S2 trials
- Bayer AG1 trial
- Celgene1 trial
- and 9 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Wilson disease1 recruiting
Closed trials
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
Completed
Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia.
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026